Back in May veteran reliever Guillermo Mota was suspended 100 games for his second positive performance enhancing drug test and today the right-hander rejoined the Giants’ active roster after serving his punishment.
At the time Mota claimed that his positive test for Clenbuterol was the result of taking a children’s cough medicine, which his agent called “severe and unfair and does not reflect the intention of the Joint Drug Prevention and Treatment Program.”
MLB did not deny that Mota’s story was plausible, yet the punishment stood and he sat out 100 games without pay. Now the 39-year-old returns to a team that just lost Melky Cabrera to a 50-game suspension and will give the Giants some middle relief innings down the stretch.
Steven Matz underwent season-ending surgery on his left elbow today. The procedure was to reposition a compressed nerve in his elbow.
Matz, 26, has struggled over 13 starts, posting a 6.08 ERA with a 48/19 K/BB ratio in 66.2 innings. That line was, obviously, a function of the bum nerve in the bum elbow. Trouble aside, Matz is expected to be ready for Opening Day in 2018.
Back in April the Mariners designated outfielder Leonys Martin for assignment. He cleared waivers, accepted an assignment to Triple-A Tacoma and proceeded to hit .312/.352/.506 in 84 minor league games, leading to the Mariners calling him up on July 30.
In 19 games since then he’s hit a bit better than he did back in April, but not great: .230/.266/.426. So they just designated him for assignment again. The Rainers only have six more games this season, so he’s likely not going back there. Given that he’s arbitration eligible and the M’s are unlikely to tender him a contract, he’s likely to elect free agency once he clears waivers. Which he will, because he’s making nearly $5 million this year.
Odd year for Martin, who will likely be competing for a roster spot someplace next spring.